Malvern Instruments Acquires NanoSight

October 3, 2013
BioPharm International Editors

Malvern Instruments has acquired NanoSight, the UK-based nanoparticle characterization company.

Malvern Instruments, a provider of instrumentation for materials and biophysical characterization, has acquired nanoparticle characterization company NanoSight. The acquisition was completed on Sept. 27, 2013.
 
NanoSight has developed and commercialized Nanoparticle Tracking Analysis (NTA). The company’s instrumentation and software enable multi-parameter analysis and characterization of many different types of nanoscale particles. Nanosight’s ability to analyze particle size, concentration, zeta potential, and aggregation, closely aligns with Malvern’s Zetasizer range, extending Malvern’s solutions for those working at the nanoscale. 
 
NanoSight will continue to operate from its current facilities in Amesbury, Wiltshire, UK, under the existing management team.

Source: NanoSight